Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CBUS 
Cibus Global LLC (CBUS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: CBUS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $14.4
1 Year Target Price $14.4
| 2 | Strong Buy |
| 1 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -81.23% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 74.85M USD | Price to earnings Ratio - | 1Y Target Price 14.4 |
Price to earnings Ratio - | 1Y Target Price 14.4 | ||
Volume (30-day avg) 4 | Beta 1.69 | 52 Weeks Range 1.20 - 6.10 | Updated Date 09/17/2025 |
52 Weeks Range 1.20 - 6.10 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -10.45 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -1923.47% |
Management Effectiveness
Return on Assets (TTM) -10.5% | Return on Equity (TTM) -158.94% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 70938521 | Price to Sales(TTM) 15.45 |
Enterprise Value 70938521 | Price to Sales(TTM) 15.45 | ||
Enterprise Value to Revenue 14.64 | Enterprise Value to EBITDA -1.15 | Shares Outstanding 52540500 | Shares Floating 36417941 |
Shares Outstanding 52540500 | Shares Floating 36417941 | ||
Percent Insiders 33.53 | Percent Institutions 29 |
Upturn AI SWOT
Cibus Global LLC
Company Overview
History and Background
Cibus Global LLC is a privately held company focused on gene editing technologies. Founded in 2001, it has developed the Rapid Trait Development System (RTDS) for precision breeding and trait development in agriculture. It aims to improve crop yields and sustainability without introducing foreign DNA.
Core Business Areas
- Trait Development: Development and licensing of non-GMO traits for various crops using RTDS technology.
- RTDS Licensing: Licensing the RTDS technology platform to other agricultural companies and research institutions.
- Seed Production: Production of seeds with improved traits developed via RTDS and selling them.
Leadership and Structure
Cibus Global LLC is led by a management team with expertise in plant biology, genetics, and business development. The organizational structure is based on functional departments, with a strong emphasis on research and development.
Top Products and Market Share
Key Offerings
- Canola Traits: Cibus focuses on developing herbicide-tolerant and yield-enhanced canola traits. It's difficult to assess their specific market share due to their privately held status and the licensing model. Competitors include Bayer, Corteva, and BASF.
- Market Share (%):
- Rice Traits: Cibus has been involved in improving rice traits such as yield and disease resistance. Market share data is not publicly available. Competitors include Bayer, Corteva, and Syngenta.
- Flax Traits: Cibus focuses on improving Flax traits. It's difficult to assess their specific market share due to their privately held status and the licensing model. Competitors include Bayer, Corteva, and BASF.
Market Dynamics
Industry Overview
The agricultural biotechnology industry is experiencing rapid growth, driven by the need for increased food production and sustainable farming practices. Gene editing technologies are gaining prominence as a faster and more precise alternative to traditional breeding methods.
Positioning
Cibus Global LLC positions itself as an innovator in gene editing, offering a non-GMO solution for crop improvement. Its RTDS technology provides a competitive advantage in speed and precision.
Total Addressable Market (TAM)
The total addressable market for gene-edited crops is projected to reach billions of dollars. Cibus is positioned to capture a significant share of this market through its technology licensing and trait development efforts.
Upturn SWOT Analysis
Strengths
- Proprietary RTDS technology
- Non-GMO approach
- Rapid trait development
- Expertise in gene editing
- Focus on sustainable agriculture
Weaknesses
- Privately held, limited access to capital
- Reliance on licensing agreements
- Regulatory hurdles for gene-edited crops
- Limited commercialized products compared to larger competitors
Opportunities
- Expanding RTDS licensing partnerships
- Developing new traits for a wider range of crops
- Capitalizing on the growing demand for sustainable agriculture
- Exploring new applications of gene editing in agriculture
Threats
- Competition from larger agricultural companies with more resources
- Negative public perception of gene-edited crops
- Changing regulatory landscape for gene editing
- Potential for competing technologies to emerge
Competitors and Market Share
Key Competitors
- Bayer (BAYRY)
- Corteva (CTVA)
- BASF (BASFY)
- Syngenta (Now ChemChina)
Competitive Landscape
Cibus has a competitive advantage in its non-GMO approach and RTDS technology, but it faces challenges from larger companies with greater resources and established market presence.
Growth Trajectory and Initiatives
Historical Growth: Cibus's growth has been driven by the increasing adoption of gene editing technologies in agriculture. Its strategic partnerships and licensing agreements have contributed to its growth.
Future Projections: Future growth is projected to be strong, driven by increasing demand for sustainable and high-yielding crops. Analyst estimates are not available for private companies.
Recent Initiatives: Recent initiatives include expanding RTDS licensing agreements and developing new traits for key crops.
Summary
Cibus Global LLC is a gene editing company with a promising technology and a non-GMO approach. Its strength lies in its RTDS platform, but it faces challenges due to competition and regulatory hurdles. Expanding licensing agreements and securing funding are crucial for continued growth. More information would be required for a more complete analysis.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Cibus Global LLC Website
- Industry Reports
- News Articles
- Company Filings (where available)
Disclaimers:
The information provided is based on publicly available sources and may not be entirely accurate or complete. Financial data is limited due to Cibus Global LLC's private status. Market share data is based on general industry estimates and may not reflect precise figures.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cibus Global LLC
Exchange NASDAQ | Headquaters San Diego, CA, United States | ||
IPO Launch date 2023-06-01 | Co-Founder, Interim CEO, President, COO & Director Dr. Peter R. Beetham B.Sc., Ph.D. | ||
Sector Healthcare | Industry Biotechnology | Full time employees 157 | Website https://www.cibus.com |
Full time employees 157 | Website https://www.cibus.com | ||
Cibus, Inc., an agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products. It focuses on trait productivity in the productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients, which enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was founded in 2001 and is headquartered in San Diego, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.